4//SEC Filing
THERASENSE INC 4
Accession 0001267399-04-000033
CIK 0001073695operating
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 2:38 PM ET
Size
12.2 KB
Accession
0001267399-04-000033
Insider Transaction Report
Form 4
THERASENSE INCTHER
THOMPSON RICHARD P
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2004-04-05$5.75/sh−5,000$28,750→ 0 totalExercise: $21.25From: 1988-08-08Exp: 2012-04-19→ Common Stock (5,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2004-04-05$22.00/sh−30,000$660,000→ 0 totalExercise: $5.00From: 1988-08-08Exp: 2010-09-29→ Common Stock (30,000 underlying) - Disposition to Issuer
Common Stock
2004-04-05$27.00/sh−31,200$842,400→ 0 total
Footnotes (3)
- [F1]Disposed of pursuant to a merger agreement between the Issuer, Abbott Laboratories and a wholly-owned subsidiary of Abbott Laboratories.
- [F2]This option vests on the one-year anniversary from the date of grant and was cancelled pursuant to the merger agreement between the Issuer, Abbott Laboratories and a wholly owned subsidiary of Abbott Laboratories in exchange for a cash payment per underlying share equal to $27.00 less the exercise price.
- [F3]This option vests over a three year period and was cancelled pursuant to the merger agreement between the Issuer, Abbott Laboratories and a wholly-owned subsidiary of Abbott Laboratories in exchange for a cash payment per underlying share equal to $27.00 less the exercise price.
Documents
Issuer
THERASENSE INC
CIK 0001073695
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001073695
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 2:38 PM ET
- Size
- 12.2 KB